Our research has revealed the differences in abundance of glycerol and quinolinic acid between responders and non-responders, yet further investigation is needed to understand the correlation between these metabolites with immunotherapy efficacy in patients with advanced EGFR+ NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.